Tinea Cruris

• FDA label_change · 2025-03-06
  FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved a supplemental application for Ciclopirox Olamine filed by Padagis Israel Pharmaceuticals Ltd, resulting in changes to the prod…

• FDA label_change · 2020-04-09
  FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)

  FDA approved a supplemental application for NAFTIN (naftifine hydrochloride) from Legacy Pharma USA Inc. to update the product labeling.

• FDA label_change · 2019-12-03
  FDA Approved: NAFTIFINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for naftifine hydrochloride from Sun Pharmaceutical Industries, Inc., updating the labeling for …

• FDA label_change · 2019-10-28
  FDA Approved: NAFTIFINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a Sun Pharmaceutical supplemental application for Naftifine Hydrochloride, updating the product labeling for the topical antifu…

• FDA label_change · 2016-06-07
  FDA Approved: LUZU — Supplemental Application (Bausch Health US, LLC)

  FDA approved a supplemental application for LUZU (luliconazole) to update its labeling.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2015-01-26
  FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for OXISTAT (oxiconazole nitrate) submitted by ANI Pharmaceuticals, Inc.